Results 61 to 70 of about 49,423 (253)
Emerging Topical and Systemic JAK Inhibitors in Dermatology [PDF]
, 2019 Accumulating data on cellular and molecular pathways help to develop novel therapeutic strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic dermatitis, two clinically and immunologically well-defined disorders.
Ghoreschi, Kamran +2 more
core +1 more source
Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
Frontiers in Medicine, 2023 Alopecia areata (AA) is a non-scarring hair loss disorder. Alopecia totalis (AT) and alopecia universalis (AU) are the severe subtypes of AA. Age of onset before 6 years of age, disease duration of more than 1 year, and extensive alopecia involving more ...
Lu Cai +7 more
doaj +1 more source
Treatment of Alopecia Areata Totalis and Universalis with Cortisone Acetate
Journal of Investigative Dermatology, 1952 Calvin J. Dillaha, Stephen Rothman
openalex +4 more sources
Establishing and Prioritising Research Questions for the Treatment of Alopecia Areata: The Alopecia Areata Priority Setting Partnership [PDF]
, 2017 BACKGROUND: Alopecia areata is a common hair loss disorder that results in patchy to complete hair loss. Many uncertainties exist around the most effective treatments for this condition. OBJECTIVES: To identify uncertainties in alopecia areata management
Brockley, J.R. +14 more
core +2 more sources
Alopecia Totalis in a Five-Year-Old Boy: A Case Report
Open Access Macedonian Journal of Medical Sciences, 2022 Background: Alopecia totalis (AT) represent the severe form of alopecia areata with a worse prognosis. In population the prevalences of alopecia totalis, is 0,08%.
Harapan Parlindungan Ringoringo
semanticscholar +1 more source
Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
Dermatology Research and Practice, 2023 Background. Alopecia areata (AA) is a common form of noncicatricial hair loss of unknown cause, affecting 0.1-0.2% of the general population. Most evidence supports the hypothesis that it is disease of the hair follicle of autoimmune nature mediated by T-
Zainab A. Kamil +2 more
doaj +1 more source
Dermatology and Therapy, 2020 Introduction Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes.
Joanna Nowaczyk +4 more
doaj +1 more source
Journal of Dermatology and Dermatologic Surgery, 2021 Janus kinase (JAK) inhibitors have been identified as an effective treatment option for severe alopecia areata (AA), but response is variable among patients.
Erinolaoluwa F Araoye, Crystal Aguh
doaj +1 more source
Is Alopecia a Clinical Symptom in Kawasaki Disease? [PDF]
Journal of Kerman University of Medical Sciences, 2014 A 20-months-old infant was admitted with prolonged fever, bilateral non-purulent conjunctivitis, strawberry tongue, lip cracking and maculopapular rash. Left branch coronary aneurysm formation was detected in Color-Doppler echocardiography. The diagnosis
Mohammad Mehdi Bagheri +3 more
doaj
Acta Dermato-Venereologica, 2018 Treatment of alopecia totalis and alopecia universalis is often challenging and unsatisfactory. Recently, Janus kinase inhibitor has shown promising results.
Jung-Won Shin +6 more
doaj +1 more source